Evaluation of Efficacy and Safety for Dipeptidyl peptidase-4 Inhibitors in Elderly Type 2 Diabetes Mellitus
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: LIM, Jeonghyun (Seoul Veterans Hospital, Seoul, South-Korea)
- Co-author(s): Hong, H. (Sumin, Seoul, South-Korea)
Ryu, L. (Jaegon, Seoul, South-Korea)
Background :The dipeptidyl peptidase-4 (DPP-4) inhibitors do not have appreciable adverse effect such as increase in body weight or hypoglycemia. and they are particularly suitable for elderly patients.Aims:To evaluate the efficacy and safety of DPP-4 inhibitors for reducing blood glucose levels in elderly patients with type 2 diabetes mellitus of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.